Center for the
ICSPP~ for Empathic Human Sciences and Services
What happened in 2010? Here's the explanation:
Dr. Peter Breggin and Colleagues
Launch New Reform Organization
Peter R. Breggin, MD is no longer affiliated with the Center for the Study of Psychiatry, informally known as International Center for the Study of Psychiatry and Psychology, which he founded and led from 1972-2002. On September 8, 2010, a FORUM binding Arbitration Panel reaffirmed Dr. Breggin's ownership and control of the URL icspp.org and supported his right to direct the URL to this new website. For more details please read Dr. and Mrs. Breggin's writeup: Why We Left. Join Peter Breggin and many of his closest colleagues in continuing psychiatric reform. Details about the Center for the Study of Empathic Therapy are available at the new Breggin reform website. In 2019, Dr. Breggin updated the name of our nonprofit organization to more fully describe the reform activities: the International Center for the Study of Patient-Oriented Psychiatry.
In 2010 we announced:
Dr. Peter Breggin his wife, Ginger Breggin and their colleagues have formed a new reform organization that puts the focus back on the individual and not the diagnosis or the drug--the Center for the Study of Empathic Therapy, Inc. We have dual purposes: First, to carry forward Dr. Breggin's 40-year effort to expose the scientific and ethical hazards of biopsychiatric theory and practices including psychiatric diagnoses, drugs, and ECT. And second, to encourage and inspire humane and ethical empathic social services and therapies that assist individuals and families toward better and more successful lives without the harmful effects of biopsychiatric interventions. For more than 5 decades, Dr. Peter Breggin, has been informing the professions, media and the public about the potential dangers of drugs, electroshock, psychosurgery, involuntary treatment, and the biological theories of psychiatry for over four decades. He is the author of dozens of scientific articles and nineteen professional books about psychiatric medication, the FDA and drug approval process, the evaluation of clinical trials, and standards of care in psychiatry and related fields. Dr. Breggin has brought about important reform accomplishments including stopping the resurgence of lobotomy in the early 1970s, alerting the public and the Food and Drug Administration about unexposed hazards of various psychiatric drugs resulting in drug label changes, and advocating for the protection of children, the elderly and other vulnerable persons from the abusive treatments of biopsychiatry. At the same time Dr. Breggin has been a staunch advocate of caring empathic therapies and services--a subject of special attention at the Empathic Therapy Conference April 2012 in Syracuse, NY.
Copyright 2010-2019 Peter R. Breggin, MD